Status:
UNKNOWN
Flaxseed in Controlling Blood Pressure of Patients
Lead Sponsor:
B.P. Koirala Institute of Health Sciences
Conditions:
Hypertension
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Hypertension is one of the major risk factor for global mortality. Approximately half of 17 million cardiovascular deaths worldwide are accounted for HTN. Multiple research for cost-effective medicati...
Eligibility Criteria
Inclusion
- Age of the patient above 18 years.
- Patients who agree to take only physician advised medicine.
- Patient who strictly follow diet as advised.
- Patients taking single antihypertensive drug with equivalent doses.
Exclusion
- Patient suffering from serious or recurrent infections.
- Pregnancy or breast feeding women, immunodeficiency or HIV patient.
- Patient with finding of any mental abnormality, which would interfere with or be affected by the study procedure .
- Patient with history of bleeding disorders.
- Hypersensitivity reaction or allergy to flaxseed.
- History of surgery within past 6 weeks
- Patient who do not will to give informed consent.
- Alcohol consumption \> 30 U/day..
- Cigarette smoking \> 2 pack/day
- Patients taking multiple antihypertensive drugs.
Key Trial Info
Start Date :
August 15 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 15 2021
Estimated Enrollment :
72 Patients enrolled
Trial Details
Trial ID
NCT04759508
Start Date
August 15 2021
End Date
October 15 2021
Last Update
July 20 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.